Recombinant arginine-degrading enzymes in metabolic anticancer therapy and bioanalytics

Cell Biology International

Volumn 39, Issue 3, 2015, Pages 246-252

  Stasyk, Oleh V ^a   Boretsky, Yuriy R ^a,b   Gonchar, Mykhailo V ^a,c   Sibirny, Andriy A ^a,c  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b LVIV STATE UNIVERSITY OF PHYSICAL CULTURE   (Ukraine)

^c UNIVERSITY OF RZESZÓW   (Poland)

Author keywords

Arginine deprivation; Cancer; Metabolic therapy

Indexed keywords

ARGINASE 1; ARGININE; ARGININE DECARBOXYLASE; ARGININE DEIMINASE; ARGININOSUCCINATE SYNTHASE; CANAVANINE; DIHYDROFOLATE REDUCTASE; NEUTRALIZING ANTIBODY; NITRIC OXIDE DONOR; ORNITHINE CARBAMOYLTRANSFERASE; PEGARGIMINASE; PEMETREXED; RECOMBINANT ENZYME; THYMIDYLATE SYNTHASE; ANTINEOPLASTIC AGENT; ARGINASE; ARGINASE I, HUMAN; HYDROLASE; RECOMBINANT PROTEIN;

AMPEROMETRIC BIOSENSOR; APOPTOSIS; AUTOPHAGY; CANCER THERAPY; ENZYME THERAPY; FLUOROMETRY; HETEROLOGOUS EXPRESSION; HUMAN; IMMUNOGENICITY; LIVER CELL CARCINOMA; MELANOMA; NONHUMAN; REVIEW; TUMOR CELL; BIOSYNTHESIS; GENETICS; METABOLISM; NEOPLASMS;

BACTERIA (MICROORGANISMS);

ANTINEOPLASTIC AGENTS; ARGINASE; ARGININE; HUMANS; HYDROLASES; NEOPLASMS; RECOMBINANT PROTEINS;

EID: 84923111990     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10383     Document Type: Review

References (30)

1. Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, YuanM, Syed N, Lo Nigro, Lattanzio C, Chmielewska-Kassassir L, TomlinsonM, Roylance I,Whitaker R,WarrenHC, Neal AY, Frezza D, Beltran C, Jones L, Chelala LJ, Wu C, Bomalaski BW, Jackson JS, Lu RC, Crook YJ, Lemoine T, Mather NR, Foster S, Sosabowski J, Avril J, Li N, Szlosarek CF (2014) Prognostic and therapeutic impact of argininosuccinate synthetase-1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res 74(3): 896-907.
2. Bobak YP, Vynnytska BO, Kurlishchuk YV, Sibirny AA, Stasyk OV (2010) Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes. Cell Biol Int 34: 1085-89.
3. Chen OI, Lyniv LS, Igumentseva NI, Barska ML, Sybirna NO, Stasyk OV (2011) Effect of nitric oxide donor on viability of human leukemic cells upon arginine deprivation. Studia Biologica 5(2): 17-28.
4. Cheng PN, Lam TL, Lam WM, Tsui SM, Cheng AW, Lo WH, Leung YC (2007) Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 67(1): 309-17.
5. Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T, Szlosarek PW (2010) Arginine deprivation and argininosuccinate synthetase expression in thetreatment of cancer. Int J Cancer 126(12): 2762-72.
6. Delage B, Luong P, Maharaj L, O'Riain C, Syed N, Crook T, Hatzimichael E, Papoudou-Bai A, Mitchell TJ, Whittaker SJ, Cerio R, Gribben J, Lemoine N, Bomalaski J, Li CF, Joel S, Fitzgibbon J, Chen LT, Szlosarek PW (2012) Promotermethylation of argininosuccinate synthetase-1 sensitises lymphomas to argininedeiminase treatment, autophagy and caspasedependent apoptosis. Cell Death Dis 3: e342.
7. Huang HY, Wu WR, Wang YH, Wang JW, Fang FM, Tsai JW, Li SH, Hung HC, Yu SC, Lan J, Shiue YL, Hsing CH, Chen LT, Li CF (2013) ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance. Clin Cancer Res 19: 2861-72.
8. Fayura LR, Boretsky YR, Pynyaha YV, Wheatley DN, Sibirny AA (2013) Improved method for expression and isolation of the Mycoplasma hominis arginine deiminase from the recombinant strain of Escherichia coli. J Biotechnol 167(4): 420-6.
9. Feun L, You M, Wu CJ, Kuo MT, Wangpaichitr M, Spector S, Savaraj N (2008) Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des 14(11): 1049-57.
10. Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ (2009) Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res 69(2): 700-8.
11. Kuo MT, Savaraj N, Feun LG (2010) Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget 1(4): 246-51.
12. Misawa S, Aoshima M, Takaku H, Matsumoto M, Hayashi H (1994) High-level expressionof Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an antitumor enzyme. J Biotechnol 36(2): 145-55.
13. Morris SM, Jr. (2006) Arginine: beyond protein. Am J Clin Nutr 83(2): 508S-12S.
14. Pavlyk I, Rzhepetskyy Y, Jagielski AK, Drozak J, Wasik A, Pereverzieva G, Olchowik M, Kunz-Schughart LA, Stasyk O, Redowicz MJ (2014) Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of b-actin arginylation. Amino Acids (in press). DOI: 10.1007/s00726-014-1857-1.
15. Phillips MM, Sheaff MT, Szlosarek PW (2013) Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges. Cancer Res Treat 45(4): 251-62.
16. Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues AL, Satriano J, Seong GJ, Wilcox G, Wu N, Gilad GM (2013) Agmatine: clinical applications after 100 years in translation. Drug Discov Today 18(17-18): 880-93.
17. Shuvayeva G, Bobak Y, Igumentseva N, Titone R, Morani F, Stasyk O, Isidoro C (2014) Single amino acid arginine deprivation triggers pro-survival autophagic response in ovarian carcinoma SCOV3. BioMed Res Int (in press). DOI: 10.1155/2014/505041.
18. Stasyuk N, Smutok O, Gayda G, Koval'chuk. Y, GoncharM(2011) A new bi-enzyme potentiometric sensor for arginine analysis based on recombinant human arginase I and commercial urease. J Mat Sci Eng 1(6): 819-27.
19. Stasyuk N, Serkiz R, Mudry S, Gayda G, Zakalskiy A, Koval'chuk Y, Gonchar M, Nisnevitch M (2011) Recombinant human arginase I immobilized on gold and silver nanoparticles: preparation and properties. Nanotech Dev e3: 11-5.
20. Stasyuk N, Smutok O, Gayda G, Vus B, Koval'chuk Y, GoncharM (2012) A reagentless amperometric L-arginine-selective biosensor based on recombinant human arginase I. Biosens Bioelectr 37: 46-52.
21. Stasyuk N, Gaida G, Gonchar M (2013) L-arginine assay with the use of arginase I. Appl Biochem Microbiol 49(5): 529-34.
22. Stone EM, Glazer ES, Chantranupong L, Cherukuri P, Breece RM, Tierney DL, Curley SA, Iverson BL, Georgiou G (2010) Replacing Mn(2+) with Co(2+) in human arginase enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines. ACS ChemBiol 5(3): 333-42.
23. Stone E, Chantranupong L, Gonzalez C, O'Neal J, Rani M, VanDenBerg C, Georgiou G (2012) Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy. J Control Release 158(1): 171-9.
24. Tsui SM, Lam WM, Lam TL, Chong HC, So PK, Kwok SY, Arnold S, Cheng PN, Wheatley DN, Lo WH, Leung YC (2009) Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC). Cancer Cell Int 9: 9.
25. Vynnytska BO, Mayevska OM, Kurlishchuk YV, Bobak YP, Stasyk OV (2011) Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells. Anticancer Drugs 22(2): 148-57.
26. Vynnytska-Myronovska B, Bobak Y, Garbe Y, Dittfeld C, Stasyk O, Kunz-Schughart LA (2012) Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation. Int J Cancer 130: 2164-75.
27. Vynnytska-Myronovska B, Kurlishchuk Y, Bobak Y, Dittfeld C, Kunz-Schughart LA, Stasyk O (2013) Three-dimensional environment renders cancer cells profoundly less susceptible to a single amino acid starvation. Amino Acids 45(5): 1221-30.
28. Wheatley DN (2004) Controlling cancer by restricting argininavailability: arginine-catabolizing enzymes as anticanceragents. Anticancer Drugs 15: 825-33.
29. Wheatley DN, Kilfeather R, Stitt A, Campbell E (2005) Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines. Cancer Lett 227(2): 141-52.
30. Zakalskiy AE, Zakalska OM, Rzhepetskyy YA, Potocka N, Stasyk OV, Horak D, Gonchar MV (2012) Overexpression of (His)(6)-tagged human arginase I in Saccharomyces cerevisiae and enzyme purification using metal affinity chromatography. Protein Expr Purif 81: 63-8.